Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
5.377
Zitationen
29
Autoren
2012
Jahr
Abstract
Preoperative chemoradiotherapy improved survival among patients with potentially curable esophageal or esophagogastric-junction cancer. The regimen was associated with acceptable adverse-event rates. (Funded by the Dutch Cancer Foundation [KWF Kankerbestrijding]; Netherlands Trial Register number, NTR487.).
Ähnliche Arbeiten
Global cancer statistics, 2012
2015 · 27.300 Zit.
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 · 6.411 Zit.
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 · 6.272 Zit.
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
2016 · 4.542 Zit.
Global Cancer Incidence and Mortality Rates and Trends—An Update
2015 · 3.682 Zit.
Autoren
- Pieter van Hagen
- Maarten C.C.M. Hulshof
- J. Jan B. van Lanschot
- Ewout W. Steyerberg
- Mark I. van Berge Henegouwen
- Bas P. L. Wijnhoven
- Dick J. Richel
- Grard A. P. Nieuwenhuijzen
- Geke A.P. Hospers
- Johannes J. Bonenkamp
- Miguel A. Cuesta
- R.J.B. Blaisse
- Olivier R. Busch
- F.J.W. ten Kate
- G.J. Creemers
- C.J.A. Punt
- John Theodorus Plukker
- Henk M.W. Verheul
- Ernst Jan Spillenaar Bilgen
- Herman van Dekken
- Maurice J.C. van der Sangen
- Tom Rozema
- Katharina Biermann
- Jannet C. Beukema
- Anna H.M. Piet
- Caroline M. van Rij
- Janny G. Reinders
- H.W. Tilanus
- Ate van der Gaast